SWOG clinical trial number
SWOG-9462 (NABTC-9404) (NCI T94-0034)
A Phase I Trial and Pharmacokinetic Study of the Sequential Administration of Carmustine (BCNU) and Temozolomide in Patients with CNS or Systemic Tumors Refractory to Standard Therapy
Closed
Phase
Accrual
90%
Abbreviated Title
A Phase I Trial and Pharmacokinetic Study of the Sequential Administration of Carmustine (BCNU) and Temozolomide in Patients with CNS or Systemic Tumors Refractory to Standard Therapy
Activated
07/28/1995
Closed
08/15/1997
Research committees
Brain Cancer